Patents by Inventor Hafid BELHADJ-TAHAR

Hafid BELHADJ-TAHAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds derived from normemantine and use of same in the medical field
    Patent number: 9714212
    Abstract: The present invention concerns novel chemical compounds corresponding to formulae (I) and (II): (I) (II) which, when marked with fluorine-18, can be used as markers of NMDA receptors for carrying out studies with a scanner.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: July 25, 2017
    Assignee: M2I DEVELOPMENT
    Inventors: Olivier Guerret, Samuel Dufour, Hafid Belhadj-Tahar
  • Dendrimer compositions, methods of synthesis, and uses thereof
    Patent number: 9603953
    Abstract: The disclosure relates to novel dendrimer conjugates and the methods of synthesizing the same, as well as systems and methods utilizing the dendrimer conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease diagnosis and/or therapy, etc.))).
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: March 28, 2017
    Inventors: Guanghua Yang, Hafid Belhadj-Tahar, Nouredine Sadeg
  • DENDRIMER COMPOSITIONS, METHODS OF SYNTHESIS, AND USES THEREOF
    Publication number: 20160303261
    Abstract: The disclosure relates to novel dendrimer conjugates and the methods of synthesizing the same, as well as systems and methods utilizing the dendrimer conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease diagnosis and/or therapy, etc.))).
    Type: Application
    Filed: January 13, 2014
    Publication date: October 20, 2016
    Inventors: Hafid BELHADJ-TAHAR, Nouredine SADEG, Yvon COULAIS
  • NOVEL CHEMICAL COMPOUNDS DERIVED FROM NORMEMANTINE AND USE OF SAME IN THE MEDICAL FIELD
    Publication number: 20160107982
    Abstract: The present invention concerns novel chemical compounds corresponding to formulae (I) and (II): (I) (II) which, when marked with fluorine-18, can be used as markers of NMDA receptors for carrying out studies with a scanner.
    Type: Application
    Filed: May 27, 2014
    Publication date: April 21, 2016
    Applicant: M2I DEVELOPMENT
    Inventors: Olivier GUERRET, Samuel DUFOUR, Hafid BELHADJ-TAHAR